Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors

Arcturus Therapeutics Holdings Inc. , a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and... | December 13, 2021

Related Keywords

China ,California ,United States ,San Diego ,Japan ,Akanuma ,Tochigi ,Jing Marantz ,Jingl Marantz ,Joseph Payne ,Krystal Biotech Inc ,Global Medical Affairs ,Linkedin ,Twitter ,Janssen Pharmaceuticals Inc ,Cystic Fibrosis Foundation ,Janssen Pharmaceutical Companies Of Johnson ,Nasdaq ,Takeda Pharmaceutical Company ,Merck Co Inc ,Head Of Medical Affairs At Alnylam Pharmaceuticals ,Marantz ,Us Medical Affairs ,Ultragenyx Pharmaceutical Inc ,Arcturus Therapeutics Holdings Inc ,Millennium Pharmaceuticals ,Head Of Medical Affairs At Acceleron Pharma ,Mrna Technology ,Arcturus Therapeutics Holdings ,Business Wire ,Arcturus Board ,Senior Vice President ,Medical Affairs ,Acceleron Pharma ,Alnylam Pharmaceuticals ,Vice President ,Latin America Medical Affairs ,Alexion Pharmaceuticals ,Krystal Biotech ,Janssen Pharmaceuticals ,Janssen Pharmaceutical Companies ,Ultragenyx Pharmaceutical ,Takeda Pharmaceutical Company Limited ,Cystic Fibrosis ,Arcturus Therapeutics Holdings Inc Stock Exchange ,News ,Information ,Press Release ,Arcturus ,Herapeutics ,Oldings ,Reading ,Messenger ,Na ,Medicines ,Company ,Ocused ,N ,The ,Development ,F ,Nfectious ,Disease ,Vaccines ,End ,Significant ,Opportunities ,Ithin ,Iver Arct Us03969t1097 ,